13 withdrawn. 13 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Withdrawn 13 |
| Phase 2 | 4 | Withdrawn 4 |
Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1) AMDC-USR, Placebo - Stress Urinary Incontinence | Phase 3 | Withdrawn | Cook MyoSite | 2025-06-01 | 2024-08-27 | |
| GetHealthy-OA: A Program to Improve Pain and Function for Patients With Knee Osteoarthritis, Obesity, and Depression Fisetin, GetHealthy-OA mind-body program, Placebo oral capsule - Knee Osteoarthritis, Obese | Phase 2 / Phase 3 | Withdrawn | Cale Andrew Jacobs, PhD | 2023-04-01 | 2023-05-01 | |
| Anti-suicidal Effects of Buprenorphine In Depressed Individuals Belbuca Buccal Product, Placebo - Suicidal Ideation, Major Depressive Disorder | Phase 3 | Withdrawn | New York State Psychiatric Institute | 2022-10-10 | 2023-11-14 | |
| Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department Ketamine, Midazolam, Placebo - Acute Pain, Depression | Phase 2 / Phase 3 | Withdrawn | Maria Pacella | 2019-12-01 | 2020-02-11 | |
| Deep Brain Stimulation to Relieve Depression Medtronic Activa SC DBS, Lead Model 3387 - Treatment Resistant Depression | Phase 3 | Withdrawn | Jordan F. Karp | 2018-06-01 | 2018-08-06 | |
| The Impact of Ketamine on the Reward Circuitry of Suicidal Patients Ketamine Hydrochloride - Suicidal Ideation, Suicide | Phase 3 | Withdrawn | Massachusetts General Hospital | 2017-02-01 | 2017-03-03 | |
| A Study to Decrease Suicidal Thinking Using Ketamine 0.2 mg/kg ketamine, placebo - Depression, Suicide | Phase 3 | Withdrawn | United States Naval Medical Center, San Diego | 2016-08-01 | 2019-09-03 | |
| Groups for Regaining Our Wellbeing (GROW) Mindfulness-Based Stress Reduction, Cognitive Processing Therapy - Posttraumatic Stress Disorder, Depression | Phase 2 / Phase 3 | Withdrawn | US Department of Veterans Affairs | 2014-04-01 | 2014-07-02 | |
| Major Depressive Disorder With Mixed Features Lurasidone 20 mg, Lurasidone 60 mg, Placebo - Major Depressive Disorder | Phase 3 | Withdrawn | Sumitomo Pharma America, Inc. | 2012-01-01 | 2012-12-13 | |
| Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT) CATCH-IT, AMPE - Depression, Anxiety | Phase 3 | Withdrawn | University of Chicago | 2010-09-01 | 2012-12-17 | |
| Trial of Kuvan in Lesch-Nyhan Disease sapropterin - Behavioral Manifestations of Lesch-Nyhan Disease | Phase 2 / Phase 3 | Withdrawn | University of California, San Diego | 2009-04-01 | 2019-08-02 | |
| A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence 10% Phenylephrine hydrochloride gel - Faecal Incontinence | Phase 3 | Withdrawn | S.L.A. Pharma AG | 2007-02-01 | 2015-05-19 | |
| Clozapine IM and Aggression in Schizophrenic Patients clozapine, haloperidol - Schizophrenia | Phase 3 | Withdrawn | Beersheva Mental Health Center | 2013-07-24 |
Depression (8) · Depressive Disorder, Major (2) · Suicidal Ideation (2) · Suicide (2) · Acute Pain (1) · Aggression (1) · Anxiety Disorders (1) · Depressive Disorder, Treatment-Resistant (1) · Encopresis (1) · Lesch-Nyhan Syndrome (1) · Lower Urinary Tract Symptoms (1) · Nocturnal Enuresis (1) · Obesity (1) · Osteoarthritis, Knee (1) · Schizophrenia (1)
Behavior (13) · Mental Disorders (8) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Depressive Disorder (3) · Mood Disorders (3) · Self-Injurious Behavior (3) · Elimination Disorders (2) · Neurologic Manifestations (2) · Nutritional and Metabolic Diseases (2) · Aberrant Motor Behavior in Dementia (1) · Arthritis (1) · Body Weight (1) · Brain Diseases (1)
Ketamine (3) · 2-cyclohexylidenhydrazo-4-phenyl-thiazole (1) · Clozapine (1) · Haloperidol (1) · Lurasidone Hydrochloride (1) · Midazolam (1) · Mindfulness-Based Stress Reduction (1) · fisetin (1) · sapropterin (1)
Beersheva Mental Health Center (1) · Cale Andrew Jacobs, PhD (1) · Cook MyoSite (1) · Jordan F. Karp (1) · Maria Pacella (1) · Massachusetts General Hospital (1) · New York State Psychiatric Institute (1) · S.L.A. Pharma AG (1) · Sumitomo Pharma America, Inc. (1) · US Department of Veterans Affairs (1) · United States Naval Medical Center, San Diego (1) · University of California, San Diego (1) · University of Chicago (1)
United States (8) · Israel (1) · United Kingdom (1)
Baruch Spivak, MD (1) · Benjamin Van Voorhees, MD (1) · Cale Jacobs, PhD (1) · Chanoch Midownik, MD (1) · David J. Kearney, MD (1) · Dawn Ionescu, M.D. (1) · Jeffrey M Miller, MD (1) · Marc A Capobianco (1) · Maria L Pacella, PhD (1) · Melissa Kaufman, M.D., Ph.D. (1) · Mina M Rizk, MD (1) · Susan Clark, MD FRCS (1) · Valdimir Lerner, MD, PhD (1) · William L Nyhan, MD, PhD (1)